Martin Ullrich

1.2k total citations
55 papers, 835 citations indexed

About

Martin Ullrich is a scholar working on Radiology, Nuclear Medicine and Imaging, Surgery and Cancer Research. According to data from OpenAlex, Martin Ullrich has authored 55 papers receiving a total of 835 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Radiology, Nuclear Medicine and Imaging, 14 papers in Surgery and 11 papers in Cancer Research. Recurrent topics in Martin Ullrich's work include Radiopharmaceutical Chemistry and Applications (17 papers), Adrenal and Paraganglionic Tumors (13 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Martin Ullrich is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (17 papers), Adrenal and Paraganglionic Tumors (13 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Martin Ullrich collaborates with scholars based in Germany, Czechia and United States. Martin Ullrich's co-authors include U. Hagen, Jens Pietzsch, Jaroslav Hanuš, František Štĕpánek, Christian G. Ziegler, Graeme Eisenhofer, Jiřı́ Dohnal, Svenja Nölting, Michael Bachmann and Ashley Grossman and has published in prestigious journals such as Journal of the American Chemical Society, SHILAP Revista de lepidopterología and Langmuir.

In The Last Decade

Martin Ullrich

50 papers receiving 795 citations

Peers

Martin Ullrich
Yawen Guo China
Bart J. Crielaard Netherlands
Kira Foygel United States
Sarah Tam United States
Swati Gupta United States
Yawen Guo China
Martin Ullrich
Citations per year, relative to Martin Ullrich Martin Ullrich (= 1×) peers Yawen Guo

Countries citing papers authored by Martin Ullrich

Since Specialization
Citations

This map shows the geographic impact of Martin Ullrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Ullrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Ullrich more than expected).

Fields of papers citing papers by Martin Ullrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Ullrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Ullrich. The network helps show where Martin Ullrich may publish in the future.

Co-authorship network of co-authors of Martin Ullrich

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Ullrich. A scholar is included among the top collaborators of Martin Ullrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Ullrich. Martin Ullrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gross, Thomas P., et al.. (2025). Radioresistant mouse pheochromocytoma cell lines. Frontiers in Oncology. 15. 1517132–1517132.
2.
Ullrich, Martin, Falco Reissig, Zbyněk Nový, et al.. (2025). It’s a match: use of the radionuclide theranostic pair 133La/225Ac for the radiopharmacological characterization of EGFR-targeted single-domain antibodies. EJNMMI Radiopharmacy and Chemistry. 10(1). 31–31.
3.
Ullrich, Martin, Robert Wodtke, Florian Brandt, et al.. (2024). The heterobivalent (SSTR2/albumin) radioligand [67Cu]Cu-NODAGA-cLAB4-TATE enables efficient somatostatin receptor radionuclide theranostics. Theranostics. 14(14). 5371–5387. 3 indexed citations
4.
Mitwasi, Nicola, Martin Ullrich, Manja Kubeil, et al.. (2023). Specific and safe targeting of glioblastoma using switchable and logic-gated RevCAR T cells. Frontiers in Immunology. 14. 1166169–1166169. 9 indexed citations
5.
Ullrich, Martin, Florian Brandt, Reik Löser, Jens Pietzsch, & Robert Wodtke. (2023). Comparative Saturation Binding Analysis of 64Cu-Labeled Somatostatin Analogues Using Cell Homogenates and Intact Cells. ACS Omega. 8(26). 24003–24009. 3 indexed citations
6.
Benešová, Martina, Jana Havlíčková, Jan Kotek, et al.. (2022). Cyclam with a phosphinate-bis(phosphonate) pendant arm is a bone-targeting carrier of copper radionuclides. Dalton Transactions. 51(24). 9541–9555. 4 indexed citations
7.
Ullrich, Martin, Susan Richter, Stephan Drukewitz, et al.. (2022). Epigenetic drugs in somatostatin type 2 receptor radionuclide theranostics and radiation transcriptomics in mouse pheochromocytoma models. Theranostics. 13(1). 278–294. 7 indexed citations
8.
Ziegler, Christian G., Carina Riediger, Martin Ullrich, et al.. (2022). Case report: Incidentally discovered case of pheochromocytoma as a cause of long COVID-19 syndrome. Frontiers in Endocrinology. 13. 967995–967995. 1 indexed citations
9.
Brandt, Florian, Markus Laube, Martin Ullrich, et al.. (2022). Sulfur [18F]Fluoride Exchange Reaction Enables Rapid Access to 18F-Labeled PET Tracers. SHILAP Revista de lepidopterología. 127–127. 1 indexed citations
10.
Richter, Susan, Nicole Bechmann, Michael Bachmann, et al.. (2021). HIF2alpha-Associated Pseudohypoxia Promotes Radioresistance in Pheochromocytoma: Insights from 3D Models. Cancers. 13(3). 385–385. 15 indexed citations
11.
Ullrich, Martin, Kristof Zarschler, O. Lebeda, et al.. (2021). Radiolabelled Cyclic Bisarylmercury: High Chemical and in vivo Stability for Theranostics. ChemMedChem. 16(17). 2645–2649. 7 indexed citations
12.
Bechmann, Nicole, Martin Ullrich, Nan Qin, et al.. (2019). Impact of Extrinsic and Intrinsic Hypoxia on Catecholamine Biosynthesis in Absence or Presence of Hif2α in Pheochromocytoma Cells. Cancers. 11(5). 594–594. 29 indexed citations
13.
Ullrich, Martin, Mirko Peitzsch, Anja Feldmann, et al.. (2018). Strain-specific metastatic phenotypes in pheochromocytoma allograft mice. Endocrine Related Cancer. 25(12). 993–1004. 7 indexed citations
14.
Bergmann, Ralf, Martin Ullrich, Marieta Toma, et al.. (2017). An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatment. BMC Cancer. 17(1). 790–790. 16 indexed citations
15.
Ziegler, Christian G., Martin Ullrich, Andrew V. Schally, et al.. (2012). Anti-tumor effects of peptide analogs targeting neuropeptide hormone receptors on mouse pheochromocytoma cells. Molecular and Cellular Endocrinology. 371(1-2). 189–194. 10 indexed citations
16.
Ullrich, Martin, Jaroslav Hanuš, Jiřı́ Dohnal, & František Štĕpánek. (2012). Encapsulation stability and temperature-dependent release kinetics from hydrogel-immobilised liposomes. Journal of Colloid and Interface Science. 394. 380–385. 38 indexed citations
17.
Ullrich, Martin, et al.. (1986). Fortschritte beim Kristallisieren in Schneckenmaschinen. Chemie Ingenieur Technik. 58(7). 590–592. 1 indexed citations
18.
Ullrich, Martin, et al.. (1970). Zur kontinuierlichen Herstellung von Lösungen. Chemie Ingenieur Technik. 42(21). 1321–1324.
19.
Ullrich, Martin, et al.. (1970). Untersuchungen an einem Schneckenverdampfer. Chemie Ingenieur Technik. 42(1). 1–5. 1 indexed citations
20.
Ullrich, Martin. (1969). Entmischungserscheinungen in Kugelschüttungen. Chemie Ingenieur Technik. 41(16). 903–907. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026